Health Resources Hub / Neurologic Disorders / Neurofibromatosis Type 1 (NF1) Neurofibromatosis Type 1 (NF1)

News

FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1

FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1

February 12, 2026

1

© 2026 MJH Life Sciences^®

All rights reserved.

Home About Us News Contact Us